The excited-state lifetime is an intrinsic property of
fluorescent
molecules that can be leveraged for multiplexed imaging. An advantage
of fluorescence lifetime-based multiplexing is that signals from multiple
probes can be gathered simultaneously, whereas traditional spectral
fluorescence imaging typically requires multiple images at different
excitation and emission wavelengths. Additionally, lifetime and spectra
could both be utilized to expand the multiplexing capacity of fluorescence.
However, resolving exogenous molecular probes based exclusively on
the fluorescence lifetime has been limited by technical challenges
in analyzing lifetime data. The phasor approach to lifetime analysis
offers a simple, graphical solution that has increasingly been used
to assess endogenous cellular autofluorescence to quantify metabolic
factors. In this study, we employed the phasor analysis of FLIM to
quantitatively resolve three exogenous, antibody-targeted fluorescent
probes with similar spectral properties based on lifetime information
alone. First, we demonstrated that three biomarkers that were spatially
restricted to the cell membrane, cytosol, or nucleus could be accurately
distinguished using FLIM and phasor analysis. Next, we successfully
resolved and quantified three probes that were all targeted to cell
surface biomarkers. Finally, we demonstrated that lifetime-based quantitation
accuracy can be improved through intensity matching of various probe–biomarker
combinations, which will expand the utility of this technique. Importantly,
we reconstructed images for each individual probe, as well as an overlay
of all three probes, from a single FLIM image. Our results demonstrate
that FLIM and phasor analysis can be leveraged as a powerful tool
for simultaneous detection of multiple biomarkers with high sensitivity
and accuracy